Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor A retrospective review was performed of 305 ...
Is Major Pathologic Response the Best Surrogate End Point for Neoadjuvant Trials? The following represents disclosure information provided by authors of this manuscript. All relationships are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results